1. Report Overview

1.1. Global Biopharmaceuticals Contract Manufacturing Market Overview

1.2. Why You Should Read This Report

1.3. How This Report Delivers

1.4. Key Questions Answered By This Analytical Report

1.5. Who Is This Report For?

1.6. Methodology

1.6.1. Primary Research

1.6.2. Secondary Research

1.6.3. Market Evaluation & Forecasting Methodology

1.7. Frequently Asked Questions (FAQ)

1.8. Associated Visiongain Reports

1.9. About Visiongain

2. Biopharmaceutical Contract Manufacturing: Executive Summary

3. Introduction to the Biopharmaceuticals Contract Manufacturing Market

3.1. What is Biopharmaceutical Contract Manufacturing?

3.2. Types of Services in Biopharmaceuticals Contract Manufacturing

3.2.1. Process Development

3.2.2. Fill & Finish Operations

3.2.3. Analytical & Quality Control Studies

3.2.4. Packaging

3.3. Types of Products in Biopharmaceuticals Contract Manufacturing

3.3.1. Biologics

3.3.2. Biosimilar

3.4. Factors Impacting Biopharmaceuticals Contract Manufacturing Market



4. Biopharmaceuticals Contract Manufacturing Market Outlook

4.1. Trends in Biopharmaceuticals Contract Manufacturing Industry

4.1.1. Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs

4.1.2. Increasing outsourcing of biopharmaceuticals-related manufacturing activities

4.1.3. Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market

4.1.4. Increasing productivity and efficiency of biopharmaceuticals manufacturing processes

4.1.5. Uptake of single-use production systems by the biopharmaceutical manufacturing industry

4.1.6. Asia emerging as hot destination for biopharmaceutical manufacturing

4.2. Market Drivers and Restraints

4.2.1. Market Drivers

4.2.1.1. Increasing confidence of pharmaceutical industry in CDMOs capabilities

4.2.1.2. High level of outsourcing of newly approved drugs by smaller biotech companies to boost the growth

4.2.1.3. Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers

4.2.2. Market Restraints

4.2.2.1. Increasing shortage of skilled workforce in the biopharmaceutical industry

4.2.2.2. Expensive and complex manufacturing equipment requirements pose as entry barriers

4.2.2.3. Complicated and stringent regulatory requirements hinder market growth

4.2.2.4. Transfer complexity

4.3. Biopharmaceuticals Contract Manufacturing future opportunities

4.3.1. High number studies involving biopharmaceuticals

4.3.2. Potential of biopharmaceuticals to treat previously untreatable diseases

4.3.3. High R&D spend of Biopharmaceutical-focused companies

4.4. PESTEL Analysis

4.5. The commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals

4.6. Growth of biologics

4.7. Biopharmaceuticals pipeline

4.8. Limited outsourcing amongst well-established biopharmaceutical manufacturer

4.9. The Emergence of single-use bioprocessing equipment & solutions

4.10. Pipeline analysis for Biosimilar drugs

5. Biopharmaceuticals Contract Manufacturing Market By Service

5.1. Biopharmaceuticals Contract Manufacturing Market Outlook By Service

5.2. Process Development Revenue Forecast

5.2.1. Downstream Revenue Forecast

5.2.2. Upstream Revenue Forecast

5.3. Fill & Finish Operations Revenue Forecast

5.4. Analytical & Quality Control Studies Revenue Forecast

5.5. Packaging Revenue Forecast

6. Biopharmaceuticals Contract Manufacturing Market By Product

6.1. Biopharmaceuticals Contract Manufacturing Market Outlook By Product

6.2. Biologics Revenue Forecast

6.3. Monoclonal Antibodies Revenue Forecast

6.4. Recombinant Proteins Revenue Forecast

6.5. Vaccines Revenue Forecast

6.6. Insulin Revenue Forecast

6.7. Biosimilars Revenue Forecast

7. Biopharmaceuticals Contract Manufacturing Market by Source

7.1. Biopharmaceuticals Contract Manufacturing Market Outlook by Source

7.2. Mammalian Cell Culture Revenue Forecast

7.3. Microbial Revenue Forecast

8. Biopharmaceuticals Contract Manufacturing Market By Region

8.1. North America Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.1.1. U.S. Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.1.2. Canada Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.2. Europe Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.2.1. Germany Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.2.2. France Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.2.3. UK Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.2.4. Russia Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.2.5. Rest of Europe Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.3. Asia Pacific Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.3.1. China Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.3.2. Japan Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.3.3. India Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.3.4. Southeast Asia Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.3.5. Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.4. Latin America Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.4.1. Brazil Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.4.2. Argentina Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.4.3. Rest of Latin America Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.5. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.5.1. GCC Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.5.2. South Africa Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

8.5.3. Rest of Middle East & Africa Biopharmaceuticals Contract Manufacturing Market 2020 – 2030

9. The Leading Biopharmaceuticals Contract Manufacturing Companies

9.1. Boehringer Ingelheim International GmbH

9.1.1. Company Overview

9.1.2. Product Benchmarking

9.1.3. Financials

9.1.4. Recent News

9.2. FUJIFILM Diosynth Biotechnologies

9.2.1. Company Overview

9.2.2. Product Benchmarking

9.2.3. Financials

9.2.4. Recent News

9.3. TOYOBO CO., LTD.

9.3.1. Company Overview

9.3.2. Product Benchmarking

9.3.3. Financials

9.3.4. Recent News

9.4. WuXi Biologics

9.4.1. Company Overview

9.4.2. Product Benchmarking

9.4.3. Financials

9.4.4. Recent News

9.5. Thermo Fisher Scientific Inc.

9.5.1. Company Overview

9.5.2. Product Benchmarking

9.5.3. Financials

9.5.4. Recent News

9.6. JRS PHARMA

9.6.1. Company Overview

9.6.2. Product Benchmarking

9.6.3. Recent News

9.7. Inno Bio Ventures

9.7.1. Company Overview

9.7.2. Product Benchmarking

9.7.3. Financials

9.8. AGC Biologics

9.8.1. Company Overview

9.8.2. Product Benchmarking

9.8.3. Financials

9.8.4. Recent News

9.9. AbbVie, Inc.

9.9.1. Company Overview

9.9.2. Product Benchmarking

9.9.3. Financials

9.9.4. Recent News

9.10. Binex Co., Ltd.

9.10.1. Company Overview

9.10.2. Product Benchmarking

9.10.3. Financials

9.10.4. Recent News

9.11. Samsung BioLogics

9.11.1. Company Overview

9.11.2. Product Benchmarking

9.11.3. Financials

9.11.4. Recent News

9.12. ProBioGen

9.12.1. 9.12.1 Company Overview

9.12.2. Product Benchmarking

9.12.3. Financials

9.12.4. Recent News

9.13. Rentschler Biotechnologie GmbH

9.13.1. Company Overview

9.13.2. Product Benchmarking

9.13.3. Financials

9.13.4. Recent News

9.14. Lonza

9.14.1. Company Overview

9.14.2. Product Benchmarking

9.14.3. Financials

9.14.4. Recent News

9.15. Sandoz

9.15.1. Company Overview

9.15.2. Product Benchmarking

9.15.3. Financials

9.15.4. Recent News

10. SWOT Analysis

10.1. Strength

10.2. Weakness

10.3. Opportunities

10.4. Threats

11. Conclusion & Recommendations

12. Glossary

Visiongain Report Sales Order Form

Appendix A

About Visiongain

13. Appendix

13.1. Visiongain report evaluation form

Order Form

Appendix A

About Visiongain

Appendix B

Visiongain report evaluation form

List of Figures

FIG.1 Process Development in Biopharmaceuticals Contract Manufacturing Industry

FIG.2 Fill & Finish Operations in Biopharmaceuticals Contract Manufacturing Industry

FIG.3 Estimated Average Activity Outsourced (% respondents, 2019)

FIG.4 Approximate Biopharmaceuticals Processing Facilities – by Countries (2019)

FIG.5 Outsourcing to CDMOs – by Types of Products (2019)

FIG.6 Outsourcing manufacturing of Newly Approved Drug – by size of biotech companies (%, 2019)

FIG.7 Global Top 10 Selling Drugs ($ billon, 2018)

FIG.8 R&D spend as a Percent of Total Sales (2019)

FIG.9 Global Biopharmaceutical Market ($ billion, 2016–2024)

FIG.10 Regional Split of Biopharmaceutical Adoption (2019)

FIG.11 Biologics vs. Biosimilars Approvals by US FDA

FIG.12 Number of Biologics Approved by US FDA (1960–2019)

FIG.13 Share of Pharmaceutical and Biopharmaceuticals in U.S. (2019)

FIG.14 Share of Pharmaceutical and Biopharmaceuticals Japan (2019)

FIG.15 Share of Pharmaceutical and Biopharmaceuticals Europe (2019)

FIG.16 Share of Pharmaceutical and Biopharmaceuticals China (2019)

FIG.17 Global Biopharmaceuticals Contract Manufacturing Market Size By Service, 2020 – 2030 (USD Mn)

FIG.18 Global Biopharmaceuticals Contract Manufacturing Market Share By Service, 2020, 2025, 2030 (%)

FIG.19 Process Development for Biopharmaceuticals Contract Manufacturing Market, 2020 – 2030 (USD Mn, AGR %)

FIG.20 Downstream Process Development for Biopharmaceuticals Contract Manufacturing Market, 2020 – 2030 (USD Mn, AGR %)

FIG.21 Upstream Process Development for Biopharmaceuticals Contract Manufacturing Market, 2020 – 2030 (USD Mn, AGR %)

FIG.22 Fill & Finish Operations for Biopharmaceuticals Contract Manufacturing Market, 2020 – 2030 (USD Mn, AGR %)

FIG.23 Analytical & Quality Control Studies for Biopharmaceuticals Contract Manufacturing Market, 2020 – 2030 (USD Mn, AGR %)

FIG.24 Packaging for Biopharmaceuticals Contract Manufacturing Market, 2020 – 2030 (USD Mn, AGR %)

FIG.25 Global Biopharmaceuticals Contract Manufacturing Market Size By Product, 2020 – 2030 (USD Mn)

FIG.26 Global Biopharmaceuticals Contract Manufacturing Market Share By Product, 2020, 2025, 2030 (%)

FIG.27 Biopharmaceuticals Contract Manufacturing Market for Biologics, 2020 – 2030 (USD Mn, AGR %)

FIG.28 Biopharmaceuticals Contract Manufacturing Market for Monoclonal Antibodies, 2020 – 2030 (USD Mn, AGR %)

FIG.29 Biopharmaceuticals Contract Manufacturing Market for Recombinant Proteins, 2020 – 2030 (USD Mn, AGR %)

FIG.30 Biopharmaceuticals Contract Manufacturing Market for Vaccines, 2020 – 2030 (USD Mn, AGR %)

FIG.31 Biopharmaceuticals Contract Manufacturing Market for Insulin, 2020 – 2030 (USD Mn, AGR %)

FIG.32 Biopharmaceuticals Contract Manufacturing Market for Biosimilars, 2020 – 2030 (USD Mn, AGR %)

FIG.33 Global Biopharmaceuticals Contract Manufacturing Market Size By Source, 2020 – 2030 (USD Mn)

FIG.34 Global Biopharmaceuticals Contract Manufacturing Market Share By Source, 2020, 2025, 2030 (%)

FIG.35 Biopharmaceuticals Contract Manufacturing Market for Mammalian, 2020 – 2030 (USD Mn, AGR %)

FIG.36 Biopharmaceuticals Contract Manufacturing Market for Microbial, 2020 – 2030 (USD Mn, AGR %)

FIG.37 Global Biopharmaceuticals Contract Manufacturing Market Size By Region, 2020 – 2030 (USD Mn)

FIG.38 Global Biopharmaceuticals Contract Manufacturing Market Share By Region, 2020, 2025, 2030 (%)

FIG.39 North America Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.40 North America Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)

FIG.41 U.S. Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.42 Canada Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.43 Europe Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.44 Europe Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)

FIG.45 Total pharmaceutical market sales forecast in Europe from 2012 to 2022 (Billion Euros)

FIG.46 Germany Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.47 France Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.48 UK Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.49 Russia Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.50 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.51 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.52 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)

FIG.53 China Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.54 Japan Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.55 India Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.56 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.57 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.58 Latin America Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.59 Latin America Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)

FIG.60 Brazil Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.61 Argentina Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.62 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.63 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.64 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)

FIG.65 GCC Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.66 South Africa Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.67 Rest of Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size, 2020 – 2030 (USD Mn, %)

FIG.68 Boehringer Ingelheim International GmbH: Financials (2016 – 2018)

FIG.69 Boehringer Ingelheim International GmbH: Sales by Region (2018, %)

FIG.70 Boehringer Ingelheim International GmbH: Sales by Product (2018, %)

FIG.71 TOYOBO CO., LTD.: Sales by Business Segment (2019, %)

FIG.72 TOYOBO CO., LTD.: Sales by Region (2019, %)

FIG.73 TOYOBO CO., LTD.: Healthcare Segment Sales (2012 – 2019, $ million)

FIG.74 WuXi Biologics: Sales and Net Profit Margin, 2017 – 2019 ($ million, %)

FIG.75 WuXi Biologics: Sales by Region, 2019 (%)

FIG.76 Thermo Fisher Scientific Inc.: Sales by Segment, 2019 (%)

List of Tables

Table 1 List of Novel Biologics Approved By US FDA In The Year 2019 And Their Projected Sales

Table 2 Various Biosimilars Samsung Bioepis Is Developing

Table 3 Process Development for Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 4 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Downstream 2020 2030 (USD Mn, AGR %, CAGR%)

Table 5 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Upstream 2020-2030 (USD Mn, AGR %, CAGR%)

Table 6 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Fill & Finish Operations 2020-2030 (USD Mn, AGR %, CAGR%)

Table 7 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Analytical & Quality Control Studies 2020-2030 (USD Mn, AGR %, CAGR%)

Table 8 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Packaging 2020-2030 (USD Mn, AGR %, CAGR%)

Table 9 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Biologics 2020-2030 (USD Mn, AGR %, CAGR%)

Table 10 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Monoclonal Antibodies 2020-2030 (USD Mn, AGR %, CAGR%)

Table 11 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Recombinant Proteins 2020-2030 (USD Mn, AGR %, CAGR%)

Table 12 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Vaccines 2020-2030 (USD Mn, AGR %, CAGR%)

Table 13 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Insulin 2020-2030 (USD Mn, AGR %, CAGR%)

Table 14 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Biosimilars 2020-2030 (USD Mn, AGR %, CAGR%)

Table 15 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Mammalian 2020-2030 (USD Mn, AGR %, CAGR%)

Table 16 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Microbial 2020-2030 (USD Mn, AGR %, CAGR%)

Table 17 North America Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 18 U.S. Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 19 Canada Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 20 Europe Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 21 Germany Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020 2030 (USD Mn, AGR %, CAGR%)

Table 22 France Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 23 UK Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 24 Russia Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 25 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 26 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 27 China Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 28 Japan Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 29 India Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 30 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 31 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 32 Latin America Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 33 Brazil Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 34 Argentina Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 35 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 36 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 37 GCC Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 38 South Africa Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 39 Rest of Middle East Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)

Table 40 Boehringer Ingelheim International GmbH: Product Benchmarking

Table 41 Boehringer Ingelheim International GmbH: Financial Performance (2018)

Table 42 FUJIFILM Diosynth Biotechnologies: Product Benchmarking

Table 43 TOYOBO CO., LTD.: Product Benchmarking

Table 44 TOYOBO CO., LTD.: Financial Performance (2017 – 2019)

Table 45 WuXi Biologics: Product Benchmarking

Table 46 WuXi Biologics: Financial Performance (2017 – 2019)

Table 47 Thermo Fisher Scientific Inc.: Product Benchmarking

Table 48 Thermo Fisher Scientific Inc.: Financial Performance (2017 – 2019)

Table 49 JRS PHARMA: Product Benchmarking

Table 50 Inno Bio Ventures: Product Benchmarking

Table 51 Inno Bio Ventures: Financial Performance (2019)

Table 52 AGC Biologics: Product Benchmarking

Table 53 AGC Biologics: Financial Performance (2018)

Table 54 AbbVie, Inc.: Product Benchmarking

Table 55 AbbVie, Inc.: Financial Performance (2018)

Table 56 Binex Co., Ltd.: Product Benchmarking

Table 57 Binex Co., Ltd.: Financial Performance (2017 – 2019)

Table 58 Samsung BioLogics: Product Benchmarking

Table 59 Samsung BioLogics: Financial Performance (2017 – 2019)

Table 60 ProBioGen: Product Benchmarking

Table 61 ProBioGen: Financial Performance (2018)

Table 62 Rentschler Biotechnologie GmbH: Product Benchmarking

Table 63 Rentschler Biotechnologie GmbH: Financial Performance (2018)

Table 64 Lonza: Product Benchmarking

Table 65 Lonza: Financial Performance (2017 – 2019)

Table 66 Sandoz: Product Benchmarking

Table 67 Sandoz: Financial Performance (2017 - 2019)